Several studies found polymorphisms in DHFR, MTHFR, TYMS, SLC19A1 and SLCO1B1 to be significantly associated with event-free survival (EFS) of ALL patients [10,11,12,13,14]. This evidence concerns the gene DHFR and acute lymphoblastic leukemia.